Filing Flows › Teva Pharmaceutical Industries (TEVA) › Q4 2025
Teva Pharmaceutical Industries (TEVA) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Feb 3, 2026
Teva Pharmaceutical Industries (TEVA) reported revenue of $4.7B for the fourth quarter 2025 (Q4 2025), +11% from a year earlier and +5% from the quarter before. Operating margin was 6.4%, net earnings $480M (10.2% of revenue).
Teva Pharmaceutical Industries, Q4 2025: revenue $4.7B (+11% year over year), operating margin 6.4%, net earnings $480M, operating cash flow $1.2B. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.7B | +5% | +11% |
| Gross profit | $2.7B | +15% | +25% |
| Operating profit | $300M | -66% | — |
| Net earnings | $480M | +11% | — |
| Operating cash flow | $1.2B | +214% | +101% |
| Free cash flow | $1.0B | +336% | +128% |
What changed
Revenue was $4.7B in Q4 2025, up 11% year over year and up 5% from the previous quarter. Product was the largest line at 78% of revenue.
Gross margin was 56.4%, up 6.2 points from a year earlier. Operating profit was $0.30B, a 6.4% margin (up 7.1 points year over year). Operating expenses grew 10% against revenue growth of 11%. The fastest-growing cost line was General & admin (+22%). Net earnings were $0.48B. The tax line was a benefit of $0.39B on pre-tax earnings of $0.09B.
Operating cash flow was $1.2B (up 101% year over year), 241% of net earnings. Non-cash charges added back $0.26B of depreciation and amortization and $0.05B of share-based compensation. Working capital and other items added $0.37B. Capital expenditures of $0.14B left free cash flow of $1.0B.
Questions
What was Teva Pharmaceutical Industries' revenue in the fourth quarter 2025?
Teva Pharmaceutical Industries (TEVA) reported revenue of $4.7B for the fourth quarter 2025 (Q4 2025), +11% from a year earlier and +5% from the quarter before.
Was Teva Pharmaceutical Industries profitable in the fourth quarter 2025?
Operating profit was $300M (6.4% of revenue) and net earnings $480M.